Companies: 10,795·Total market cap: $144.5T

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRNNASDAQHealthcare● Active

$56.77

+$0.30(+0.53%)

Market Cap$11.0B

P/E Ratio—

52W High$66.28

52W Low$49.26

Avg Volume2.0M

Open$56.16

Beta0.24

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BioMarin Pharmaceutical Inc.（BMRN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BMRN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$1.40Earnings history

PE Ratio (TTM)40.5×PE Ratio deep dive

Revenue (TTM)$3.2BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding191.8MShares outstanding history

Next EarningsAug 3, 2026Est.Earnings history

探索 BioMarin Pharmaceutical Inc. 数据

分析师预测$90 · Buy

股息不分红

营收$3.2B+12.87%

盈利EPS $1.82-19.11%

市盈率40.5×

财务快照

FY 2025Revenue$3.22B▲ +12.87% YoY

202320242025

FY 2025Net Income$348.9M▼ 18.26% YoY

202320242025

FY 2025EPS$1.82▼ 19.11% YoY

202320242025

TTM:Revenue: $3.24BNet Income: $268.7MEPS: $1.40View income statement →

分析师评级与目标价

Buy41 位分析师

Strong Buy

0

Buy

28

Hold

13

Sell

0

Strong Sell

0

12-Month Price Target

$50.00Low

$56.77Current

$89.93Avg Target上涨空间 58.41%

$120.00High

合计: 41 · 买入占比: 68.3%

根据过去 3 个月内 41 位华尔街分析师，BMRN 共识评级为 Buy，12 个月平均目标价 $89.93 （较现价 $56.77 上涨空间 58.41%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BioMarin Pharmaceutical Inc.

$56.77+0.53%$11.0B #2

Align Technology, Inc.

$167.74-0.33%$12.0B #3

BridgeBio Pharma, Inc.

$67.61+0.42%$13.2B #4

$52.70+0.40%$13.2B #5

Halozyme Therapeutics, Inc.

$71.53-0.10%$8.5B #6

Madrigal Pharmaceuticals, Inc.

$486.98-1.19%$11.2B

股票表现

1D+0.53%

1W+6.47%

1M+5.01%

3M-7.12%

YTD-4.48%

1Y-0.19%

5Y-27.92%

关于 BioMarin Pharmaceutical Inc.

CEOAlexander Hardy

IPO DateJul 26, 1999

Employees3,040

CountryUS

Websitebiomarin.com

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

BioMarin Pharmaceutical Inc.（BMRN）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 26, 1999 在 NASDAQ 上市。截至最近交易日，BMRN 股价为 $56.77，市值约为 $11.0B。过去12个月累计回报 -0.19%，年初至今回报 -4.48%。

根据 41 位华尔街分析师，BioMarin Pharmaceutical Inc. 股票共识评级为Buy，12个月平均目标价为 $89.93。2025 财年 BioMarin Pharmaceutical Inc. 营收 $3.2B，净利润 $348.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，BioMarin Pharmaceutical Inc.（BMRN）股价为 $56.77，在 NASDAQ 上市，52周区间为 $49.26 – $66.28。

BMRN 最新股价BMRN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议